481TiP Checkmate 722: A phase 3 trial of nivolumab with chemotherapy or ipilimumab vs chemotherapy in epidermal growth factor receptor (EGFR)-mutation, T790M-negative stage IV or recurrent non-small cell lung cancer (NSCLC) after EGFR tyrosine kinase inhibitor (TKI) therapy
2016 ◽
Vol 27
◽
pp. ix154-ix155
K. Nakagawa
◽
J.C.-H. Yang
◽
K. Park
◽
Y. Ohe
◽
Y.-L. Wu
◽
...
2016 ◽
Vol 27
(suppl_9)
◽
K. Nakagawa
◽
J.C-H. Yang
◽
K. Park
◽
Y. Ohe
◽
Y-L. Wu
◽
...
2017 ◽
Vol 32
(3)
◽
pp. 422-428
◽
Yong Won Choi
◽
Jin-Hyuk Choi
Hyun Ae Jung
◽
Jinyeong Lim
◽
Se-Hoon Lee
◽
Je-Gun Joung
◽
Yeong Jeong Jeon
◽
...
2014 ◽
Vol 32
(15_suppl)
◽
pp. e19117-e19117
Gayatri Vaidyanathan
◽
Grace K. Dy
◽
Petr Starostik
◽
Shiva Dibaj
2019 ◽
Vol 37
(6)
◽
pp. 1207-1217
Makoto Nishio
◽
Haruyasu Murakami
◽
Yuichiro Ohe
◽
Toyoaki Hida
◽
Hiroshi Sakai
◽
...
2015 ◽
Vol 10
(1)
◽
pp. 156-163
◽
Petra Hoffknecht
◽
Amanda Tufman
◽
Thomas Wehler
◽
Theo Pelzer
◽
Rainer Wiewrodt
◽
...
N. Kobayashi
◽
H. Aiko
◽
C. Kamimaki
◽
N. Mikami
◽
S. Kubo
◽
...
2018 ◽
Vol 36
(15_suppl)
◽
pp. e21223-e21223
Chong Hyun Suh
◽
Hyesun Park
◽
Kyung Won Kim
◽
Junhee Pyo
◽
Hiroto Hatabu
◽
...
Jerome H. Check
◽
Diane Check
◽
Trina Poretta
◽
James Aikins
◽
Carrie Wilson
2013 ◽
Vol 8
(7)
◽
pp. 892-898
◽
Kosuke Tanaka
◽
Akito Hata
◽
Reiko Kaji
◽
Shiro Fujita
◽
Takehiro Otoshi
◽
...
Close
Export Citation Format
Close
Share Document
Close